Baseline AI
AI document creation and data management for clinical trials
Operating in healthcare based in San Francisco, CA, USA, Baseline AI operates.
Profile
The main document in a clinical trial is the study protocol. At large companies, floors of people use the protocol to create the study data collection forms, clinical database design, error checks, analysis code, and data transformation mappings. We use AI to automate the process of creating everything from the protocol, saving not only spend on headcount but also months of time which can translate to up to $27M in direct costs + lost revenue saved for a single phase 3 trial.
Within the healthcare space, the company focuses on its core offering rather than a broad product line.
The company is recorded as being based in San Francisco, CA, USA.
Directory data places it at the Summer 2024 stage.
Its team size is recorded as 2 employees.
Directory analysis
Baseline AI is a San Francisco‑based startup that applies artificial intelligence to automate the creation of clinical trial documentation, from study protocols to data collection forms, database design, and analysis code. By streamlining these tasks, the company claims to reduce headcount costs and accelerate timelines, potentially saving up to $27 million per phase‑3 trial. The firm currently operates with a two‑person team and has not disclosed funding details.
Positioning: Baseline AI occupies a niche in the clinical research technology space, targeting efficiency gains for large pharmaceutical and biotech companies. With a small team and no disclosed funding, its market traction and scalability remain to be demonstrated.
Note: Baseline AI automates clinical trial documentation using AI.
Auto-generated directory analysis from public data · updated 11 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | San Francisco, CA, USA |
| Country | USA |
| Employees | 2 |
| Stage | Summer 2024 |
Website: www.baselinetrials.com
Browse related
Create a free account